Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

This is in addition to SK’s previous contribution of $5 million and balloons the Israeli system-maker’s fundraising total to $80 million from the likes of Fujifilm and Foxconn

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

Three authors of a research study on the efficacy of hydroxychloroquine in COVID-19 patients published in The Lancet have retracted their paper after it was met with backlash and scientific questions.

The company first rolled out its 10 special freestanding centers for coronavirus patients back in March in three states. 

Only 12% of chief financial officers of hospital and health provider organizations say they plan to cut or defer spending on digital transformation of their financial systems despite 100% saying they expect a significant revenue decline this year due to the coronavirus.

It may be time to take a long last look at the vision exam that relies on a cardboard sheet of huge letters at the top and tiny ones at the bottom.

Senior U.S. District Judge Donald E. Walter sentenced William Britt Harvey, of Lecompte, to two years in federal prison and three years of supervised release.

The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.

Capacity for optical colonoscopy across NHS England hospitals is "already stretched," so freeing up space is a top priority to screen patients who need the procedure most.